Gene Query: GEMIN2

Dataset Description Geneva Score
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 29.18
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 29.18
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 16.45
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 10.75
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 10.75
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 9.84
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 9.11
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.66
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 8.4
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 8.08
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 7.62
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 5.8
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 5.56
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.39
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.21
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.21
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.16
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 4.91
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.85
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.85
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.34
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 4.06
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.04
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.91
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.91
Lysine benzoylation is a novel histone mark [RNA-seq] 3.91
Lysine benzoylation is a novel histone mark 3.91
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 3.89
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.77
DART-seq: an antibody-free method for global m6A detection 3.75
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.7
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 3.6
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 3.6
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.58
Co-transcriptional loading of RNA export factors shapes the human transcriptome 3.48
RNAseq of HEK293 cells after Chtop knockdown 3.48
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 3.42
Single-nucleotide-resolution mapping of HBV promoters using CAGE 3.35
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 3.35
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.34
Systematic discovery of endogenous human ribonucleoprotein complexes 3.2
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.19
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 3.1
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.09
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.02
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 3.01
Gene expression changes after LOC550643 silencing 3.0
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 2.99
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.98
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.89
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 2.79
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 2.79
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.78
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.73
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 2.7
HEK293 TFAM Knockout Expression Study 2.66
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 2.59
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 2.55
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.54
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.54
N6-methyladenine DNA Modification in Glioblastoma 2.51
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.51
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 2.5
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 2.48
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.39
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.39
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 2.36
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 2.34
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 2.31
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 2.24
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 2.22
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.21
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.21
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.21
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 2.18
Gene expression changes due to PARP knockdown in human cells 2.16
Single-cell analysis of adult human ovary using 10X genomics 2.14
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.12
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.11
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.09
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.09
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.09
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.08
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 2.06
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.05
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.01
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 2.0
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.99
scRNASeq analysis of cycling cardiomyocytes 1.96
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.95
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.95
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.95
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 1.94
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 1.94
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 1.94
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.94
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 1.88
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 1.88
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 1.88
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 1.86
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 1.86
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 1.84
Global transcriptome analysis of HAP1 cells 1.82
Illumina Total RNA-seq in HeLa 1.8
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 1.72
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 1.71
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 1.7
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 1.7
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 1.69
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.67
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 1.66
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.66
HNF1A deficiency impairs β-cell fate, granule maturation and function 1.65
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 1.63
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.62
Regulation of protein translation during mitosis 1.61
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 1.59
CROP-Seq in Primary Human T Cells 1.58
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 1.58
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 1.56
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 1.53
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 1.53
Differentially expressed genes post knock down of lincDUSP26 1.51
Seletive inhibition of CDK9 in DLBCL cell lines 1.5
Human cell line and subcutaneous tumor 1.5
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.49
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 1.49
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 1.49
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.49
Next Generation Sequencing of human SMA and healthy control Motor Neurons 1.45
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.45
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 1.43
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 1.43
3’ Uridylation Expands miRNA Target Repertoire 1.42
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 1.4
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 1.4
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.39
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.39
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 1.37
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 1.36
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.36
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 1.35
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 1.35
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 1.35
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 1.35
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 1.35
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 1.35
High-efficiency RNA-based reprogramming of human primary fibroblasts 1.35
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 1.34
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.33
Genome-wide analysis of the Integrator complex (HTS) 1.33
Genome-wide analysis of the Integrator complex 1.33
Oncogenic MYC induces a dependency on the spliceosome in human cancer 1.33
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 1.32
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 1.31
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.3
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.3
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 1.29
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 1.27
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 1.27
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 1.27
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 1.27
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 1.27
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 1.26
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 1.26
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 1.26
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.25
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.24
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.24
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 1.24
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 1.24
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.24
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.23
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.22
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.21
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 1.21
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 1.21
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 1.2
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 1.2
Overexpression of NFIB and YBX1 in MCF-7 cells 1.2
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.19
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.19
Effect of drugs on transcriptomic profiles 1.18
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 1.18
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 1.18
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 1.18
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.17
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.17
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.17
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.17
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.16
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.15
ARID1A regulates condensin II distribution and chromosomal partition 1.15
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 1.15
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 1.14
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 1.14
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 1.14
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.13
Single-Cell Genotyping of Transcriptomes 1.13
Iron response of HepG2 cells 1.13
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.13
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.13
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 1.13
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.12
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.12
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.11
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.1
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.1
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.1
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 1.09
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.09
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.09
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.08
Nrf2 regulated genes in A549 cells 1.08
Identification of Nrf2 regulated genes by RNA sequencing 1.08
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.08
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.06
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.06
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.05
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 1.05
RNAseq Study in CC-671 Treated Cal-51 Cells 1.04
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 1.03
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.02
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.01
Mapping interactions for the TNIP2 hub protein 0.99
Global analysis of enhancer targets: Mosaic-seq 0.98
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.97
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.97
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.96
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.96
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.96
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 0.96
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 0.96
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.96
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.95
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 0.95
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.93
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.93
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.93
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.92
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.92
Cajal bodies are linked to genome conformation [RNA-Seq] 0.92
Cajal bodies are linked to genome conformation 0.92
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 0.92
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 0.91
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 0.91
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 0.91
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 0.91
MCF-7 as a model for functional analysis of breast cancer risk variants 0.9
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.9
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 0.9
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.89
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.89
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 0.88
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.88
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.87
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.87
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 0.87
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 0.87
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 0.86
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 0.86
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 0.86
Gene expression profile in breast cancer cells 0.86
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.86
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 0.86
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.85
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.85
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 0.85
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 0.84
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.84
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.83
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.81
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 0.81
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.8
PRDM1 inhibits proliferation of human colon cancer organoids 0.8
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.8
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.8
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.8
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 0.8
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 0.8
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.79
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 0.79
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.79
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 0.78
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 0.78
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.78
mRNA expression profile of Lymphocytes 0.77
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.77
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.77
Oncogenic roles of ARID5B in T-ALL 0.77
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.76
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 0.76
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.76
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.76
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.75
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 0.75
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 0.75
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 0.74
ETV7 and interferon response 0.74
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.74
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.74
High-resolution comparative analysis of great ape genomes 0.74
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.73
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 0.73
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.73
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 0.72
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 0.72
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 0.71
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.7
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.7
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.69
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 0.68
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.68
Determination of tRNA aminoacylation levels by high throughput sequencing 0.67
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 0.67
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 0.67
SLIGRL-induced gene expression changes in NHEK cells 0.66
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 0.66
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 0.65
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 0.65
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 0.64
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.64
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.63
Effect of PRDM11 depletion in U2932 cells 0.62
Single-cell analysis of human kidney organoids 0.62
Gene expression signatures of innate lymphoid cells from human blood 0.62
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.62
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.61
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.61
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.61
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.61
CD73 knockdown effect in pancreatic cancer cell lines 0.61
Effect of PBK knockdown on C4-2 cell transcriptome 0.61
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.6
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.59
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.59
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.59
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.59
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 0.59
Silencing p300 in MCF7 cells to study expression and alternative splicing 0.58
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.57
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.57
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.57
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.56
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.56
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.56
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 0.56
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.56
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.56
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.55
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.55
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.55
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.54
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.54
The transcriptome and chromatin accessbility landscape of mammalian germline 0.53
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.52
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.52
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.52
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.52
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.52
Transcriptional landscape changes during human embryonic stem cell derivation 0.52
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.52
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.51
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.51
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.51
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.5
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.5
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.5
The Genetic Landscape of Diamond-Blackfan Anemia 0.46
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.45
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.44
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.44
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.44
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 0.43
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.43
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.43
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.42
RNA expression analysis upon JMJD1C depletion 0.41
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.41
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.41
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.4
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.4
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.4
Effect of CHKA knockdown on C4-2 cell transcriptome 0.39
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.39
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.39
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.39
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 0.38
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.38
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.38
Modulation of nonsense-mediated decay by rapamycin 0.38
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.36
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.36
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.36
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.36
Ribosomal protein RPL26 is the principal target of UFMylation 0.36
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.35
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.35
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.35
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.35
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.34
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.34
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.33
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 0.33
Controlling for gene expression changes in transcription factor protein networks. 0.32
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.32
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 0.31
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.31
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.31
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 0.31
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.3
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.3
Global transcriptome analysis of WT versus HEB-/- hESCs 0.29
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 0.29
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.29
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.28
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.28
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.27
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.27
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.27
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.27
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.26
Identification of a LIF-responsive replication-competent human β cell 0.26
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.25
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.25
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.25
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 0.24
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 0.24
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.23
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.23
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.23
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.23
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.22
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.22
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.22
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 0.21
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 0.21
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.21
Role of FGFR1 in neuronal devlopment 0.2
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.2
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.19
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.18
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.18
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.18
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.18
Landscape and variation of RNA secondary structure across the human transcriptome 0.18
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.18
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.18
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.17
The cohesin complex prevents Myc-induced replication stress 0.17
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.16
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.15
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.15
Transcriptome-wide modulation of splicing by the exon junction complex 0.14
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.14
RNA-seq data 0.13
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.13
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.13
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.13
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.13
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.13
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.13
Polarized B -cell functions 0.13
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.12
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.12
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.12
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.12
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.11
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 0.09
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.09
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.08
The bromodomain protein BRD4 regulates splicing during heat shock 0.07
A single-cell transcriptome atlas of the human pancreas 0.06
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.06
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.06
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.05
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.05
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.04
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.04
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.04
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.04
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.04
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.04
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.03
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.02
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.02
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.02
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.01
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.01
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.01
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.01
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.01
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.0
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.0
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.0
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.0
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation